Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study. / Benthien, Kirstine Skov; Lech, Laura Victoria Jedig; Birke, Hanne; Jørgensen, Sidsel Maria; Andersen, Tina; Hansen, Stine Vest; Andersen, Jon Trærup; Karstoft, Kristian; Schiøtz, Michaela; Vermehren, Charlotte.

In: PLoS ONE, Vol. 18, No. 11 , e0294024, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Benthien, KS, Lech, LVJ, Birke, H, Jørgensen, SM, Andersen, T, Hansen, SV, Andersen, JT, Karstoft, K, Schiøtz, M & Vermehren, C 2023, 'Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study', PLoS ONE, vol. 18, no. 11 , e0294024. https://doi.org/10.1371/journal.pone.0294024

APA

Benthien, K. S., Lech, L. V. J., Birke, H., Jørgensen, S. M., Andersen, T., Hansen, S. V., Andersen, J. T., Karstoft, K., Schiøtz, M., & Vermehren, C. (2023). Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study. PLoS ONE, 18(11 ), [e0294024]. https://doi.org/10.1371/journal.pone.0294024

Vancouver

Benthien KS, Lech LVJ, Birke H, Jørgensen SM, Andersen T, Hansen SV et al. Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study. PLoS ONE. 2023;18(11 ). e0294024. https://doi.org/10.1371/journal.pone.0294024

Author

Benthien, Kirstine Skov ; Lech, Laura Victoria Jedig ; Birke, Hanne ; Jørgensen, Sidsel Maria ; Andersen, Tina ; Hansen, Stine Vest ; Andersen, Jon Trærup ; Karstoft, Kristian ; Schiøtz, Michaela ; Vermehren, Charlotte. / Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study. In: PLoS ONE. 2023 ; Vol. 18, No. 11 .

Bibtex

@article{bd8dbac8c9d54b0b8ea96d2b5b1d2bd6,
title = "Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study",
abstract = "Introduction Behavioural and psychological symptoms of dementia (BPSD) should only rarely and briefly be treated with antipsychotics. Despite recommendations to the contrary, the use of antipsychotics in nursing home residents with dementia is widespread and followed by serious adverse effects. Intervention studies on methods to reduce the use of antipsychotics in persons with dementia are few and needed. The aim of this protocol is to describe the rationale and content of the intervention DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-a hybrid effectiveness-implementation pilot study. Materials and methods This is a protocol of a prospective hybrid effectiveness-implementation pilot study. The primary aim of DECADE is to reduce the use of antipsychotic drugs by 50% in 50% of nursing home residents with dementia while maintaining or improving BPSD. The intervention is implemented in six nursing homes including approximately 190 residents with dementia and consists of Academic Detailing, medication review, education of nursing home staff, and care plans. The evaluation of feasibility and potential effectiveness is an overall assessment of all clinical and process outcomes. Logistic regression analyses will be used to investigate factors characterizing situations with prescription of antipsychotics. BPSD is analysed with a before- and after design using self-controlled case series methods and the use of antipsychotics is analysed as interrupted time series. Discussion This protocol describes a study that will provide an indication of DECADE effectiveness and a model for upscaling and further evaluation in a controlled design.",
author = "Benthien, {Kirstine Skov} and Lech, {Laura Victoria Jedig} and Hanne Birke and J{\o}rgensen, {Sidsel Maria} and Tina Andersen and Hansen, {Stine Vest} and Andersen, {Jon Tr{\ae}rup} and Kristian Karstoft and Michaela Schi{\o}tz and Charlotte Vermehren",
note = "Publisher Copyright: {\textcopyright} 2023 Benthien et al.",
year = "2023",
doi = "10.1371/journal.pone.0294024",
language = "English",
volume = "18",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11 ",

}

RIS

TY - JOUR

T1 - Protocol for DEprescribing and Care to reduce Antipsychotics in Dementia (DECADE)-A hybrid effectiveness-implementation pilot study

AU - Benthien, Kirstine Skov

AU - Lech, Laura Victoria Jedig

AU - Birke, Hanne

AU - Jørgensen, Sidsel Maria

AU - Andersen, Tina

AU - Hansen, Stine Vest

AU - Andersen, Jon Trærup

AU - Karstoft, Kristian

AU - Schiøtz, Michaela

AU - Vermehren, Charlotte

N1 - Publisher Copyright: © 2023 Benthien et al.

PY - 2023

Y1 - 2023

N2 - Introduction Behavioural and psychological symptoms of dementia (BPSD) should only rarely and briefly be treated with antipsychotics. Despite recommendations to the contrary, the use of antipsychotics in nursing home residents with dementia is widespread and followed by serious adverse effects. Intervention studies on methods to reduce the use of antipsychotics in persons with dementia are few and needed. The aim of this protocol is to describe the rationale and content of the intervention DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-a hybrid effectiveness-implementation pilot study. Materials and methods This is a protocol of a prospective hybrid effectiveness-implementation pilot study. The primary aim of DECADE is to reduce the use of antipsychotic drugs by 50% in 50% of nursing home residents with dementia while maintaining or improving BPSD. The intervention is implemented in six nursing homes including approximately 190 residents with dementia and consists of Academic Detailing, medication review, education of nursing home staff, and care plans. The evaluation of feasibility and potential effectiveness is an overall assessment of all clinical and process outcomes. Logistic regression analyses will be used to investigate factors characterizing situations with prescription of antipsychotics. BPSD is analysed with a before- and after design using self-controlled case series methods and the use of antipsychotics is analysed as interrupted time series. Discussion This protocol describes a study that will provide an indication of DECADE effectiveness and a model for upscaling and further evaluation in a controlled design.

AB - Introduction Behavioural and psychological symptoms of dementia (BPSD) should only rarely and briefly be treated with antipsychotics. Despite recommendations to the contrary, the use of antipsychotics in nursing home residents with dementia is widespread and followed by serious adverse effects. Intervention studies on methods to reduce the use of antipsychotics in persons with dementia are few and needed. The aim of this protocol is to describe the rationale and content of the intervention DEprescribing and Care to reduce Antipsychotics in DEmentia (DECADE)-a hybrid effectiveness-implementation pilot study. Materials and methods This is a protocol of a prospective hybrid effectiveness-implementation pilot study. The primary aim of DECADE is to reduce the use of antipsychotic drugs by 50% in 50% of nursing home residents with dementia while maintaining or improving BPSD. The intervention is implemented in six nursing homes including approximately 190 residents with dementia and consists of Academic Detailing, medication review, education of nursing home staff, and care plans. The evaluation of feasibility and potential effectiveness is an overall assessment of all clinical and process outcomes. Logistic regression analyses will be used to investigate factors characterizing situations with prescription of antipsychotics. BPSD is analysed with a before- and after design using self-controlled case series methods and the use of antipsychotics is analysed as interrupted time series. Discussion This protocol describes a study that will provide an indication of DECADE effectiveness and a model for upscaling and further evaluation in a controlled design.

U2 - 10.1371/journal.pone.0294024

DO - 10.1371/journal.pone.0294024

M3 - Journal article

C2 - 37943780

AN - SCOPUS:85176436214

VL - 18

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 11

M1 - e0294024

ER -

ID: 374304115